The insurance industry’s relentless competition—manifested through product cloning, cost inflation, and distribution channel conflicts—has reached unsustainable levels, according to a Shanghai Securities News investigation. Market observers warn this “race to the bottom” has spawned unethical practices including competitor defamation, illegal rebating, and misleading sales tactics, undermining the sector’s high-quality development.
No Winners in This “Volume War”
“We launched a tax-advantaged nursing care health insurance product that initially performed exceptionally well. Within months, a midsize insurer copied our model but offered higher commissions to agents—our market share evaporated overnight,” lamented an executive at a major health insurer, describing the industry’s product homogeneity crisis.
Analysis of competing nursing care insurance products reveals nearly identical coverage for 10 critical illnesses and accident-related disabilities. “When products are indistinguishable, agents naturally prioritize higher-commission options,” confirmed a Shanghai-based insurance broker.
Industry veterans identify three destructive competition patterns:
- Product cloning: 87% of new life insurance products show significant overlap with existing offerings
- Cost inflation: Distribution channel commissions have surged 32% year-over-year
- Talent poaching: 45% of agencies report losing teams to competitors offering signing bonuses
Root Causes: Growth Slowdown Meets Innovation Deficit
Long Ge, Deputy Director of the Innovation and Risk Management Research Center at UIBE, attributes the crisis to dual pressures: “Externally, premium growth has slowed to 4.7% annually—forcing cutthroat competition for market share. Internally, short-term thinking dominates, with insurers prioritizing quick profits through copycat products over genuine innovation.”
Wang Xiangnan of the Chinese Academy of Social Sciences highlights structural weaknesses: “Many insurers lack R&D capability, defaulting to imitation. Their weak bargaining power against distribution channels forces excessive fee concessions.”
Breaking the Cycle: Three Pathways to Differentiation
Industry leaders propose strategic shifts to escape the competition trap:
Regulatory Interventions
Wang suggests strengthening “filing-compliance unity” enforcement while relaxing innovation restrictions. Recent actions by provincial associations in Anhui and Fujian—mandating strict commission controls and anti-defamation rules—signal growing regulatory resolve.
Market Restructuring
Long advocates creating a unified national insurance market to dismantle local protectionism, coupled with R&D tax incentives to stimulate breakthrough products.Strategic Specialization
“The solution lies in deep vertical specialization,” emphasizes the health insurance executive. “We’re redirecting resources to underserved chronic disease management—a $28 billion opportunity currently addressed by just 3% of insurers.”
As China’s financial regulators elevate “anti-volume-war” initiatives to national priority status, the insurance sector faces a pivotal choice: continue destructive competition or reinvent through authentic differentiation. The clock is ticking—analysts estimate current practices erode industry profitability by 1.2 percentage points annually.
Related topics:
